- Origin: Missouri
- Grant awarded in: 2017
Involved Industries:
Contact Information
Support Organizations:
- BioGenerator • Cortex Innovation Community • Skandalaris Center • Square One • Startup Connection • The BALSA Group • Venture Cafe
-
Christian Harding
Co-Founder and Chief Executive Officer
-
Mario Feldman
CSO
-
Christine Szymanski
What is VaxNewMo?
VaxNewMo is dedicated to developing more affordable pneumococcal conjugate vaccines that provide broader protection against more strains of bacteria that cause pneumococcal pneumonia. To do this, we utilize our patented bioconjugation technology, which bypasses the dependency on the synthetic chemistry techniques previously required to manufacture conjugate vaccines. In essence, we have engineered the lab safe bacterium, E. coli, to manufacture pneumococcal conjugate vaccines faster, more reliable, and less expensive than traditional pharmaceutical companies can.
Company Leadership
Christian Harding
Christian Harding is Co-Founder and Chief Executive Officer for VaxNewMo.
